Literature DB >> 14605849

[Renal lesions of paraproteinemias and fibrillary glomerulopathies].

K Amann1, C S Haas.   

Abstract

The term "paraproteinemia" or dysproteinemia" refers to a group of diseases caused by specific proteins that very often leads to kidney disease. In these cases a kidney biopsy is often the first diagnostic procedure leading to the diagnosis of a systemic disease. Due to the very variable presentation of the kidney disease in paraproteinemias a diagnosis is often very difficult without specific clinical data. Therefore, we recommend systematic investigation of the kidney biopsy including routine immunohistochemical stains for kappa- and lambda-light chains and electron microscopy in elderly patients with proteinuric kidney disease of unknown origin. In the following we will briefly discuss renal manifestations and clinical symptoms in multiple myeloma with light- or heavy chain deposition (LCDD: light chain deposition disease, HCDD: heavy chain deposition disease), macroglobulinemia Waldenström (Morbus Waldenström), primary amyloidosis or so called monoclonal gammopathy of uncertain dignity (benign monoclonal gammopathy) and fibrillary glomerulopathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605849     DOI: 10.1007/s00292-003-0652-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  13 in total

Review 1.  Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.

Authors:  Pierre M Ronco; Marie-Alexandra Alyanakian; Beatrice Mougenot; Pierre Aucouturier
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

2.  Acquired Fanconi syndrome associated with IgG kappa multiple myeloma: observations on the mechanisms of impaired renal acid excretion.

Authors:  K Yonemura; H Matsushima; A Kato; T Isozaki; A Hishida
Journal:  Nephrol Dial Transplant       Date:  1997-06       Impact factor: 5.992

3.  Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.

Authors:  A M Herzenberg; M Kiaii; A B Magil
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 4.  Immunoglobulin light chain amyloidosis and the kidney.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

5.  Nodular glomerulosclerosis secondary to mu heavy chain deposits.

Authors:  H Liapis; I Papadakis; L Nakopoulou
Journal:  Hum Pathol       Date:  2000-01       Impact factor: 3.466

6.  Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

Authors:  Julie Lin; Glen S Markowitz; Anthony M Valeri; Neeraja Kambham; William H Sherman; Gerald B Appel; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 7.  Monoclonal immunoglobulin light chain-related renal diseases.

Authors:  P W Sanders; G A Herrera
Journal:  Semin Nephrol       Date:  1993-05       Impact factor: 5.299

8.  Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.

Authors:  P W Sanders; G A Herrera; K A Kirk; C W Old; J H Galla
Journal:  Lab Invest       Date:  1991-04       Impact factor: 5.662

Review 9.  Renal involvement in plasma cell dyscrasias.

Authors:  P W Sanders
Journal:  Curr Opin Nephrol Hypertens       Date:  1993-03       Impact factor: 2.894

10.  Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.

Authors:  L Zhu; G A Herrera; J E Murphy-Ullrich; Z Q Huang; P W Sanders
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.